Da Silva-Tillmann, Barbara
Wilson, Marie-Claire
Doshi, Hetal
Lievano, Fabio
Perrott, Mark
Renz, Cheryl
Funding for this research was provided by:
AbbVie
Article History
Accepted: 5 December 2021
First Online: 8 January 2022
Declarations
:
: AbbVie Inc. funded this study and participated in the study design, research, analysis, data collection, interpretation of data, review, and approval of the publication. All authors had access to relevant data and participated in the drafting, review, and approval of this publication. No honoraria or payments were made for authorship.
: Barbara Da Silva-Tillmann, Hetal Doshi, Fabio Lievano, and Cheryl Renz are full-time employees of AbbVie, and own AbbVie stock.
: Not required.
: All patients and healthcare providers provided written informed consent to participate in the study.
: Not applicable.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: All authors contributed to the study concept/design, data acquisition, analysis, and interpretation, as well as writing and critical review of the manuscript. All authors provided final approval of the submitted version.
Free to read: This content has been made available to all.